Great post @adreamer
I would be surprised if PAA ann anything regarding a CR prior to ODD.
1. It will affect the level of funding required.
2. It will affect the SP at time of pricing.
Listed companies are like rockstars, allways late to the gig. One would think they would let their timeline slip if it is in company best interests. I am sure they have plenty of work to go on with anyway
The Great Pharmaust FDA ODD Approval Sweepstake, page-168
-
- There are more pages in this discussion • 55 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $100.1M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.5¢ | $194.1K | 889.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4996 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 114999 | 4 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |